About Semaglutide
Semaglutide is a synthetic GLP-1 receptor agonist used in metabolic and endocrine research. Supplied as a lyophilized powder for laboratory investigations of incretin receptor pharmacology, glucose-regulatory signaling, and downstream pathway activity in controlled experimental systems. Each batch is verified for identity and purity using HPLC and mass spectrometry. Supplied as: Lyophilized powder Purity: >95-99(HPLC verified) Storage: Store desiccated at ?20�C for long-term. Short-term room temperature exposure (around 1 month) during shipping/handling is generally acceptable if kept sealed, dry, and protected from heat/light. Designation: FOR RESEARCH USE ONLY. Not intended for human or animal consumption.
Latest Research
Semaglutide in metabolic dysfunction-associated alcohol-related liver disease: a potential dual-target therapy for metabolic dysfunction and alcohol use.
Recent research on Semaglutide: Semaglutide in metabolic dysfunction-associated alcohol-related liver disease: a potential dual-target therapy for metabolic dysfunction and alcohol use.
Read Full Study on PubMedShort-term comparative effects of semaglutide, either alone or in conjunction with canagliflozin, on early diabetic kidney disease.
Recent research on Semaglutide: Short-term comparative effects of semaglutide, either alone or in conjunction with canagliflozin, on early diabetic kidney disease.
Read Full Study on PubMedAdditional Studies
Boerhaave's syndrome associated with glucagon-like peptide-1 receptor agonist use: a case report.
Recent research on Semaglutide: Boerhaave's syndrome associated with glucagon-like peptide-1 receptor agonist use: a case report.
Read on PubMedLate-stage generation of (14)C/(3)H-radiolabeled lysine residues via hydroformylation of peptides.
Recent research on Semaglutide: Late-stage generation of (14)C/(3)H-radiolabeled lysine residues via hydroformylation of peptides.
Read on PubMedImpact of Preoperative Semaglutide Discontinuation Timing on Postoperative Outcomes in Aesthetic Abdominoplasty: A Retrospective Comparative Study.
Recent research on Semaglutide: Impact of Preoperative Semaglutide Discontinuation Timing on Postoperative Outcomes in Aesthetic Abdominoplasty: A Retrospective Comparative Study.
Read on PubMedRe: Liu et al.: Rate and risk of nonarteritic anterior ischemic optic neuropathy with semaglutide use for diabetes and weight loss: a systematic review and meta-analysis (Ophthalmology 2026;133;589-598).
Recent research on Semaglutide: Re: Liu et al.: Rate and risk of nonarteritic anterior ischemic optic neuropathy with semaglutide use for diabetes and weight loss: a systematic review and meta-analysis (Ophthalmology 2026;133;589-59
Read on PubMedEvidence-informed guidance for the clinical use of oral semaglutide in obesity management.
Recent research on Semaglutide: Evidence-informed guidance for the clinical use of oral semaglutide in obesity management.
Read on PubMedTherapeutic development in MASH: From accelerated approval to cirrhosis trial innovation.
Recent research on Semaglutide: Therapeutic development in MASH: From accelerated approval to cirrhosis trial innovation.
Read on PubMedRelated Research
Purchase Semaglutide from Verified Peptides
High-purity research peptides with full analytical verification
- 99% Purity (HPLC Verified)
- Full Certificate of Analysis
- Same Day Dispatch
- Free UK Shipping Over £75
Research Disclaimer
The research articles and studies referenced on this page are for informational purposes only. All products are sold for research use only and are not intended for human or animal consumption. The information provided does not constitute medical advice, diagnosis, or treatment. Always consult with qualified healthcare professionals before making any decisions related to health or medical treatment.